E. Maubec

机构：Inserm, Université Paris Cité, Université Sorbonne Paris Nord, Assistance Publique – Hôpitaux de Paris, Health and Functional Exposomics · ORCID：0000-0003-1658-6686

发表论文 350 篇 · 总被引 6115 次 · h-index 40

代表论文

• When to stop immunotherapy for advanced melanoma: the emulated target trials (2024 · EClinicalMedicine · 被引 10)
• Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: a nationwide real-life study in France (NEOMEL) (2025 · British Journal of Dermatology · 被引 7)
• Methods of nivolumab administration in advanced melanoma: A comparison of patients’ clinical outcomes treated with flat dose or weight‐adjusted dose, a multicenter observational study (2024 · Cancer · 被引 5)
• Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA (2026 · European Journal of Cancer · 被引 1)
• Real-world outcomes of immune checkpoint inhibitors in people with HIV and skin cancer: a multicentre study (2025 · The Oncologist · 被引 1)
• Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel) (2025 · Annales de Dermatologie et de Vénéréologie · 被引 1)